Mineralys Therapeutics, Inc. (MLYS)

29.77 +1.56 (+5.53%) USD  |  NASDAQ  |  Feb 06, 16:00
30.31 +0.54 (+1.81%) After-Hours: 20:00
More

Mineralys Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for MLYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
Lyell Immunopharma, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade